Exact Mass: 648.171

Cyclomaltodextrin

3-Deoxy-3-[4-(3-Fluorophenyl)-1h-1,2,3-Triazol-1-Yl]-Beta-D-Galactopyranosyl 3-Deoxy-3-[4-(3-Fluorophenyl)-1h-1,2,3-Triazol-1-Yl]-1-Thio-Beta-D-Galactopyranoside

C28H30F2N6O8S (648.1814)

COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C78273 - Agent Affecting Respiratory System Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

N-Desalkyl-itraconazole

3H-1,2,4-Triazol-3-one,4-[4-[4-[4-[[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1-piperazinyl]phenyl]-2,4-dihydro-, cis-

C31H30Cl2N8O4 (648.1767)

Avatrombopag

1-(3-Chloro-5-{[4-(4-chlorothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)-1,3-thiazol-2-yl]-C-hydroxycarbonimidoyl}pyridin-2-yl)piperidine-4-carboxylate

C29H34Cl2N6O3S2 (648.1511)

Itoside B

Embigenin 2-(2-acetylrhamnoside)

5-Hydroxy-7,4-dimethoxyflavone 6-C- [ 2"-acetylrhamnosyl- (1->2) glucoside ]

(2)-4-hydroxy-3-methoxyphenyl beta-D-{6-O-[4-O-(7S,8R)-(4-hydroxy-3-methoxyphenylglycerol-8-yl)-3-methoxybenzoyl]}glucopyranoside

3-(7-methoxy-2-(3,4-methylenedioxyphenyl)benzofuran-5-yl)propyl 3-(7-methoxy-2-(3,4-methylenedioxyphenyl)benzofuran-5-yl)propanoate|3-[7-methoxy-2-(3,4-methylenedioxyphenyl)benzofuran-5-yl]propyl 3-[7-methoxy-2-(3,4-methylenedioxyphenyl)benzofuran-5-yl]propanoate

3-(7-methoxy-2-(3,4-methylenedioxyphenyl)benzofuran-5-yl)propyl 3-(7-methoxy-2-(3,4-methylenedioxyphenyl)benzofuran-5-yl)propanoate|3-[7-methoxy-2-(3,4-methylenedioxyphenyl)benzofuran-5-yl]propyl 3-[7-methoxy-2-(3,4-methylenedioxyphenyl)benzofuran-5-yl]propanoate

C38H32O10 (648.1995)

C30H32O16

SCHEMBL19923099

C32H30F6N4O4 (648.2171)

[6-[(5,7-dihydroxy-4-methyl-1,2,3,4-tetrahydronaphthalen-2-yl)oxy]-4,5-dihydroxy-3-[(E)-3-(4-hydroxyphenyl)prop-2-enoyl]oxyoxan-2-yl]methyl (E)-3-(4-hydroxyphenyl)prop-2-enoate

NCGC00385630-01![6-[(5,7-dihydroxy-4-methyl-1,2,3,4-tetrahydronaphthalen-2-yl)oxy]-4,5-dihydroxy-3-[(E)-3-(4-hydroxyphenyl)prop-2-enoyl]oxyoxan-2-yl]methyl (E)-3-(4-hydroxyphenyl)prop-2-enoate

Caylin-2

4-[4,5-bis(4-trifluoromethyl-phenyl)-2-(2-isopropoxy-4-methoxy-phenyl)-4,5-dihydro-imidazole-1-carboxyl]-piperazin-2-one

C32H30F6N4O4 (648.2171)

avatrombopag

C29H34Cl2N6O3S2 (648.1511)

B - Blood and blood forming organs > B02 - Antihemorrhagics > B02B - Vitamin k and other hemostatics C78275 - Agent Affecting Blood or Body Fluid

Cyclopentadienylbis(triphenylphosphine)cobalt(I)

C41H35CoP2 (648.1546)

RS 102221 hydrochloride

C27H32ClF3N4O7S (648.1632)

1,4,8,11-tetraazacyclotetradecane-1,4,8,11-tetraacetic acid tetrahydrochloride hydrate

C18H44Cl4N4O12 (648.171)

2-butene-1,4-bis(triphenylphosphonium chloride)

C40H36Cl2P2 (648.1669)

3-[(1Z,4Z,10Z,14Z)-13-acetyl-18-(2-carboxyethyl)-8-(1-hydroxyethenyl)-3,7,12,17-tetramethylporphyrin-21,22,23,24-tetraid-2-yl]propanoic acid;iron(4+)

C34H32FeN4O6 (648.1671)

cis Heme d

C34H32FeN4O6-2 (648.1671)

trans Heme d

C34H32FeN4O6-2 (648.1671)

7-Methyl-3-(3,4,5-trihydroxyphenyl)-4-[3,4,5-trihydroxy-6-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxymethyl]oxan-2-yl]oxy-2,8-dioxatricyclo[7.3.1.05,13]trideca-1(12),3,5(13),6,9-pentaen-11-one

Heme d cis-diol

C34H32FeN4O6-4 (648.1671)

4-[4-[4-[4-[[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-1H-1,2,4-triazol-5-one

C31H30Cl2N8O4 (648.1767)

7-methyl-3-(3,4,5-trihydroxyphenyl)-4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxy-2,8-dioxatricyclo[7.3.1.05,13]trideca-1(12),3,5(13),6,9-pentaen-11-one

7-methyl-3-(3,4,5-trihydroxyphenyl)-4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxy-2,8-dioxatricyclo[7.3.1.05,13]trideca-1(12),3,5(13),6,9-pentaen-11-one

Heme d trans-diol(2-)

C34H32FeN4O6-4 (648.1671)

6-[2-[4,5-Dihydroxy-6-methyl-2-[(3,4,5,6-tetrahydroxyoxan-2-yl)methoxy]oxan-3-yl]oxy-4,5-dihydroxy-6-methyloxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid

6-[6-[4,5-Dihydroxy-6-methyl-2-[(3,4,5,6-tetrahydroxyoxan-2-yl)methoxy]oxan-3-yl]oxy-4,5-dihydroxy-2-methyloxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid

6-({2-[({4,5-Dihydroxy-6-methyl-3-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]oxan-2-yl}oxy)methyl]-3,5,6-trihydroxyoxan-4-yl}oxy)-3,4,5-trihydroxyoxane-2-carboxylic acid

(2R,3R,4R)-2-[(2S,3R,4S,5S,6R)-2-[(2R,3S,4S,5R,6S)-3,5-Dihydroxy-2-(hydroxymethyl)-6-[(3R,4R,5R,6R)-4,5,6-trihydroxyoxan-3-yl]oxyoxan-4-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxy-3,4-dihydro-2H-pyran-6-carboxylic acid

(2R,3R,4R)-2-[(2S,3R,4S,5S,6R)-2-[(2R,3S,4S,5R,6S)-3,5-Dihydroxy-2-(hydroxymethyl)-6-[(3R,4R,5R,6R)-4,5,6-trihydroxyoxan-3-yl]oxyoxan-4-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxy-3,4-dihydro-2H-pyran-6-carboxylic acid

C23H36O21 (648.1749)

3,4,5-Trihydroxy-6-({4-hydroxy-2-methyl-6-[(3,4,5,6-tetrahydroxyoxan-2-yl)methoxy]-5-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]oxan-3-yl}oxy)oxane-2-carboxylic acid

3,4,5-Trihydroxy-6-({3-hydroxy-2-methyl-6-[(3,4,5,6-tetrahydroxyoxan-2-yl)methoxy]-5-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]oxan-4-yl}oxy)oxane-2-carboxylic acid

6-[2-[4,5-Dihydroxy-6-methyl-2-[(3,4,5,6-tetrahydroxyoxan-2-yl)methoxy]oxan-3-yl]oxy-3,5-dihydroxy-6-methyloxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid

6-({2-[({4,5-Dihydroxy-6-methyl-3-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]oxan-2-yl}oxy)methyl]-4,5,6-trihydroxyoxan-3-yl}oxy)-3,4,5-trihydroxyoxane-2-carboxylic acid

6-({6-[({4,5-Dihydroxy-6-methyl-3-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]oxan-2-yl}oxy)methyl]-2,4,5-trihydroxyoxan-3-yl}oxy)-3,4,5-trihydroxyoxane-2-carboxylic acid

[6-[(5,7-dihydroxy-4-methyl-1,2,3,4-tetrahydronaphthalen-2-yl)oxy]-4,5-dihydroxy-3-[(E)-3-(4-hydroxyphenyl)prop-2-enoyl]oxyoxan-2-yl]methyl (E)-3-(4-hydroxyphenyl)prop-2-enoate

heme d cis-diol(2-)

C34H32FeN4O6 (648.1671)

A dicarboxylic acid dianion resulting from the removal of a proton from both of the carboxy groups of heme d cis-diol.

Heme d trans-diol(2-)

C34H32FeN4O6 (648.1671)

A dicarboxylic acid dianion resulting from the removal of a proton from both of the carboxy groups of heme d trans-diol.

LPIP2 10:0

C19H39O18P3 (648.1349)

RS-102221 (hydrochloride)

C27H32ClF3N4O7S (648.1632)

RS-102221 hydrochloride is a selective 5-HT2C receptor antagonist (Ki=10 nM). RS-102221 hydrochloride shows nearly 100-fold selectivity for the 5-HT2C receptor as compared to the 5-HT2A and 5-HT2B receptors. RS-102221 hydrochloride can promote the differentiation of new nerve cells. RS-102221 hydrochloride increases food-intake and weight-gain in rats[1][2].

(3s,4s)-5-[(3s,4s)-4-(acetyloxy)-7,10-dihydroxy-9-methoxy-3-methyl-1h,3h,4h-naphtho[2,3-c]pyran-5-yl]-10-hydroxy-7,9-dimethoxy-3-methyl-1h,3h,4h-naphtho[2,3-c]pyran-4-yl acetate

2-({4,5-dihydroxy-2-[5-hydroxy-7-methoxy-2-(4-methoxyphenyl)-4-oxochromen-6-yl]-6-(hydroxymethyl)oxan-3-yl}oxy)-4,5-dihydroxy-6-methyloxan-3-yl acetate

methyl 2-[3-({3-[3,6-dihydroxy-2-(methoxycarbonyl)benzoyl]-2,4-dihydroxy-6-methylphenyl}methyl)-2,6-dihydroxy-4-methylbenzoyl]-3,6-dihydroxybenzoate

C33H28O14 (648.1479)

[(3s,5r,6s)-3-[(1r)-5,7-dioxatricyclo[4.2.1.0³,⁹]nona-3,6(9)-dien-1-yloxy]-5,6-dihydroxy-4-methyl-1-[(3,4,5-trihydroxycyclohex-2-ene-1-carbonyloxy)methyl]-2-oxabicyclo[2.2.1]heptan-3-yl]methyl 2,3,4-trihydroxybenzoate

[(3s,5r,6s)-3-[(1r)-5,7-dioxatricyclo[4.2.1.0³,⁹]nona-3,6(9)-dien-1-yloxy]-5,6-dihydroxy-4-methyl-1-[(3,4,5-trihydroxycyclohex-2-ene-1-carbonyloxy)methyl]-2-oxabicyclo[2.2.1]heptan-3-yl]methyl 2,3,4-trihydroxybenzoate

5-[4-(acetyloxy)-7,10-dihydroxy-9-methoxy-3-methyl-1h,3h,4h-naphtho[2,3-c]pyran-6-yl]-10-hydroxy-7,9-dimethoxy-3-methyl-1h,3h,4h-naphtho[2,3-c]pyran-4-yl acetate

6-[(benzoyloxy)methyl]-4,5-dihydroxy-2-{4-hydroxy-2-[(1-hydroxy-6-oxocyclohex-2-ene-1-carbonyloxy)methyl]phenoxy}oxan-3-yl benzoate

(3s,4s)-5-[(3s,4s)-4-(acetyloxy)-7,10-dihydroxy-9-methoxy-3-methyl-1h,3h,4h-naphtho[2,3-c]pyran-6-yl]-10-hydroxy-7,9-dimethoxy-3-methyl-1h,3h,4h-naphtho[2,3-c]pyran-4-yl acetate

(2s,3r,4s,5s,6r)-6-[(benzoyloxy)methyl]-4,5-dihydroxy-2-(4-hydroxy-2-{[(1r)-1-hydroxy-6-oxocyclohex-2-ene-1-carbonyloxy]methyl}phenoxy)oxan-3-yl benzoate

(2s,3r,4r,5r,6s)-2-{[(2s,3r,4s,5s,6r)-4,5-dihydroxy-2-[5-hydroxy-7-methoxy-2-(4-methoxyphenyl)-4-oxochromen-6-yl]-6-(hydroxymethyl)oxan-3-yl]oxy}-4,5-dihydroxy-6-methyloxan-3-yl acetate

7-methyl-4-[(3,4,5-trihydroxy-6-{[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]methyl}oxan-2-yl)oxy]-3-(3,4,5-trihydroxyphenyl)-2,8-dioxatricyclo[7.3.1.0⁵,¹³]trideca-1(12),3,5(13),6,9-pentaen-11-one

(2s,3r,4s,5s,6r)-6-[(benzoyloxy)methyl]-4,5-dihydroxy-2-(4-hydroxy-2-{[(1s)-1-hydroxy-6-oxocyclohex-2-ene-1-carbonyloxy]methyl}phenoxy)oxan-3-yl benzoate

(2s,3r,4s,5s,6r)-6-[(benzoyloxy)methyl]-4,5-dihydroxy-2-{4-hydroxy-2-[(1-hydroxy-6-oxocyclohex-2-ene-1-carbonyloxy)methyl]phenoxy}oxan-3-yl benzoate

3-[2-(2h-1,3-benzodioxol-5-yl)-7-methoxy-1-benzofuran-5-yl]propyl 3-[2-(2h-1,3-benzodioxol-5-yl)-7-methoxy-1-benzofuran-5-yl]propanoate

C38H32O10 (648.1995)

[(2r,3s,4s,5r,6s)-3,4,5-trihydroxy-6-{[(1r,2s,3r,5r,6r,8s)-6-hydroxy-2-[(4-hydroxybenzoyloxy)methyl]-8-methyl-9,10-dioxatetracyclo[4.3.1.0²,⁵.0³,⁸]decan-3-yl]oxy}oxan-2-yl]methyl 3,4,5-trihydroxybenzoate

[(2r,3s,4s,5r,6s)-3,4,5-trihydroxy-6-{[(1r,2s,3r,5r,6r,8s)-6-hydroxy-2-[(4-hydroxybenzoyloxy)methyl]-8-methyl-9,10-dioxatetracyclo[4.3.1.0²,⁵.0³,⁸]decan-3-yl]oxy}oxan-2-yl]methyl 3,4,5-trihydroxybenzoate

{6-[(5,7-dihydroxy-4-methyl-1,2,3,4-tetrahydronaphthalen-2-yl)oxy]-4,5-dihydroxy-3-{[(2e)-3-(4-hydroxyphenyl)prop-2-enoyl]oxy}oxan-2-yl}methyl (2e)-3-(4-hydroxyphenyl)prop-2-enoate

5-[4-(acetyloxy)-7,10-dihydroxy-9-methoxy-3-methyl-1h,3h,4h-naphtho[2,3-c]pyran-5-yl]-10-hydroxy-7,9-dimethoxy-3-methyl-1h,3h,4h-naphtho[2,3-c]pyran-4-yl acetate